Recherche
Résultats 1-3 de 3
-
Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
Journal of Clinical Oncology, American Society of Clinical Oncology, 23-06-2021, 39 (29), 3251-3260Article dans une revue scientifique -
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial.
Journal of Clinical Oncology, American Society of Clinical Oncology, 20-03-2021, 39 (18), 1959-1970Article dans une revue scientifique -
Randomized Phase III Trial Evaluating Subcutaneous Rituximab for the First-Line Treatment of Low-Tumor Burden Follicular Lymphoma: Results of a LYSA Study
Journal of Clinical Oncology, American Society of Clinical Oncology, 18-04-2023, 41 (19), 3523-3533Article dans une revue scientifique